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Abstract. 
 
The tumor suppressor p53 binding protein 1
(53BP1) binds to the DNA-binding domain of p53
and enhances p53-mediated transcriptional activation.
53BP1 contains two breast cancer susceptibility gene 1
COOH terminus (BRCT) motifs, which are present in
several proteins involved in DNA repair and/or DNA
damage–signaling pathways. Thus, we investigated the
potential role of 53BP1 in DNA damage–signaling
pathways. Here, we report that 53BP1 becomes hyper-
phosphorylated and forms discrete nuclear foci in re-
sponse to DNA damage. These foci colocalize at all
time points with phosphorylated H2AX (
 
g
 
-H2AX),
which has been previously demonstrated to localize at
sites of DNA strand breaks. 53BP1 foci formation is
not restricted to 
 
g
 
-radiation but is also detected in re-
sponse to UV radiation as well as hydroxyurea, camp-
tothecin, etoposide, and methylmethanesulfonate treat-
ment. Several observations suggest that 53BP1 is
regulated by ataxia telangiectasia mutated (ATM) after
DNA damage. First, ATM-deﬁcient cells show no
53BP1 hyperphosphorylation and reduced 53BP1 foci
formation in response to 
 
g
 
-radiation compared with
cells expressing wild-type ATM. Second, wortmannin
treatment strongly inhibits 
 
g
 
-radiation–induced hyper-
phosphorylation and foci formation of 53BP1. Third,
53BP1 is readily phosphorylated by ATM in vitro.
Taken together, these results suggest that 53BP1 is an
ATM substrate that is involved early in the DNA dam-
age–signaling pathways in mammalian cells.
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g
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Introduction
 
Cells have evolved various sophisticated pathways to
sense and overcome DNA damage as a mechanism to pre-
serve the integrity of the genome. Environmental attacks
like radiation or toxins, as well as spontaneous DNA le-
sions, trigger checkpoint activation and consequent cell
cycle arrest and/or apoptosis. One key protein that co-
ordinates DNA repair with cell cycle progression and
apoptosis is the tumor suppressor protein p53. P53 is acti-
vated and posttranslationally modified in response to
DNA damage (Appella and Anderson, 2000). These mod-
ifications include phosphorylation by ataxia telangiectasia
mutated (ATM),
 
1
 
 a protein kinase implicated in DNA
damage–signaling pathways (Canman et al., 1998; Khanna
et al., 1998). By transcriptionally activating genes involved
in cell cycle control, DNA repair, and apoptosis, p53 par-
ticipates in the maintenance of the genomic integrity after
DNA damage.
P53 interacts with p53 binding protein 1 (53BP1). 53BP1
has been identified in a yeast two hybrid screen as a pro-
tein that interacts with the central DNA–binding domain
of p53 (Iwabuchi et al., 1994). Similar to breast cancer sus-
ceptibility gene 1
 
 
 
(BRCA1; Ouchi et al., 1998; Zhang et al.,
1998a; Chai et al., 1999), 53BP1 enhances p53-dependent
transcription (Iwabuchi et al., 1998). Interestingly, the
COOH terminus of 53BP1 contains tandem BRCA1
COOH terminus (BRCT) motifs. This motif was first iden-
tified in the COOH-terminal region of BRCA1 and has
since been found in a large number of proteins involved in
various aspects of cell cycle control, recombination, and
DNA repair in mammals and yeast (Koonin et al., 1996;
Bork et al., 1997; Callebaut and Mornon, 1997). The func-
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Abbreviations used in this paper: 
 
ATM, ataxia telangiectasia mutated;
BRCA1, breast cancer susceptibility gene 1; BRCT, BRCA1 COOH ter-
minus; DNA-PK, DNA-dependent protein kinase; 53BP1, binding protein
1; GST, glutathione 
 
S
 
-transferase; PI3K, phosphatidylinositol 3–kinase. 
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tion of the BRCT domain is not known. However, evi-
dence suggests that BRCT domains may mediate protein–
protein interactions (Zhang et al., 1998b).
The presence of BRCT domains in 53BP1 and the re-
ported interaction with p53 prompted us to investigate
whether 53BP1 is involved in DNA damage–response
pathways. Here we report that 53BP1 becomes hyperphos-
phorylated and rapidly relocates to the sites of DNA
strand breaks in response to ionizing radiation. 53BP1 foci
formation is reduced in ATM-deficient cells and can be in-
hibited by wortmannin in ATM wild-type cells. Moreover,
radiation-induced hyperphosphorylation of 53BP1 is ab-
sent in cells treated with wortmannin, as well as in ATM-
deficient cells. Taken together, these results strongly sug-
gest that 53BP1 participates in DNA damage–signaling
pathways and is regulated by ATM after 
 
g
 
-radiation.
 
Materials and Methods
 
Cell Culture and Treatments with 
DNA-damaging Agents
 
Cells were grown in RPMI 1640 medium supplemented with 10% fetal bo-
vine serum at 37
 
8
 
C with 5% CO
 
2
 
. FT169A and YZ5 cells were provided
by Dr. Y. Shilon (Tel Aviv University, Ramat Aviv, Israel). Cells grown
on coverslips were irradiated in a JL Shepherd 
 
137
 
Cs radiation source at a
rate of 1 Gy/min for doses of 1–5 Gy or 10 Gy/min for a dose of 10 Gy. UV
light was delivered in a single pulse (50 J/m
 
2
 
) using a Stratalinker UV
source (Stratagene). Before UV irradiation, the culture medium was re-
moved and the medium was replaced immediately after irradiation. All
cells were returned to the incubator for recovery and harvested at the in-
dicated times. Genotoxic agents and other drugs were used at the indi-
cated concentrations. After a 1-h exposure, the cells were harvested for
immunostaining.
 
Immunoprecipitation, Immunoblotting, 
and Immunostaining
 
Immunoprecipitation, immunoblotting, and immunostaining were per-
formed as described previously (Scully et al., 1997). Rabbit polyclonal
anti-53BP1 serum E7 was raised against a glutathione 
 
S
 
-transferase (GST)
fusion protein encoding residues 338–671 of 53BP1. Mouse anti-53BP1
monoclonal antibodies were raised against a mix of three GST fusion pro-
teins encoding residues 1–337, 338–671, and 1,331–1,664, respectively, of
53BP1. Antiphospho-H2AX antibody was generated as described previ-
ously (Rogakou et al., 1999).
 
ATM Kinase Assay
 
ATM was immunoprecipitated from K562 cells using anti-ATM antibody
Ab3 (Oncogene Research Products). Aliquots of the ATM–protein A
Sepharose immunocomplexes were resuspended in 25 
 
m
 
l kinase buffer (10
mM Hepes, pH 7.4, 50 mM NaCl, 10 mM MgCl
 
2
 
, 10 mM MnCl
 
2
 
, 1 mM
DTT, 10 nM ATP) and incubated for 20 min at 30
 
8
 
C with 10 
 
m
 
Ci of [
 
g
 
32
 
]P-
ATP and 1 
 
m
 
g of various affinity-purified GST fusion proteins containing
different fragments of 53BP1.
 
Results
 
53BP1 Forms Nuclear Foci in Response to 
Various Types of DNA Damage
 
Several proteins, including BRCA1 and Mre11/Rad50/
Nbs1, form DNA damage–regulated, subnuclear foci in
the cell. To determine whether 53BP1 participates in
DNA damage–signaling pathways, we examined 53BP1 lo-
calization after various types of DNA damage using sev-
eral anti-53BP1 polyclonal and monoclonal antibodies
generated for this study. All antibodies specifically recog-
nize endogenous, as well as HA-tagged, full-length 53BP1
as examined by Western blotting, immunoprecipitation,
and immunostaining (data not shown). As shown in Fig. 1,
53BP1 is diffusely localized in the nuclei of normal cells,
but relocates to discrete subnuclear foci structures in re-
sponse to ionizing radiation (e.g., 1 Gy). These 53BP1 foci
can be detected as early as 5 min after irradiation (data not
shown). Higher doses of radiation (e.g., 10 Gy) lead to
more but smaller 53BP1 foci (Fig. 1). The number of foci
reaches a peak at 
 
z
 
30 min after radiation. Thereafter, the
foci number slowly decreases, whereas the foci size in-
creases (data not shown).
Foci formation is also observed in response to other
DNA-damaging events. UV radiation induced the forma-
tion of numerous small foci, similar to that induced by
4NQO (a UV-mimetic agent) and hydroxyurea (Fig. 1).
Treatment with the DNA topoisomerase I poison camp-
tothecin or the topoisomerase II poison etoposide (VP16),
which cause DNA single strand and double strand breaks,
respectively, also resulted in the formation of 53BP1 foci.
Similar results were obtained with the alkylating agent me-
thylmethanesulfonate. However, cisplatin, a DNA cross-
linking agent, induced only a few 53BP1 foci during the
first hour after drug application, whereas the protein ki-
nase inhibitor UCN-01 and the antimitotic agent paclitaxel
(Taxol; Bristol-Meyers Squibb Co.) did not induce 53BP1
foci formation. Thus, different types of DNA damage trig-
ger the recruitment of 53BP1 into discrete nuclear foci.
 
53BP1 Colocalizes with 
 
g
 
-H2AX in 
Response to DNA Damage
 
The time course of 53BP1 foci formation and disappear-
ance is very similar to that recently described for phos-
phorylated H2AX (Rogakou et al., 1999; Paull et al.,
2000). H2AX is one of the histone H2A molecules in
mammalian cells and becomes rapidly phosphorylated
after exposure of cells to ionizing radiation (Rogakou et
al., 1999; Paull et al., 2000). Phosphorylated H2AX
(
 
g
 
-H2AX) appears within 1–3 min as discrete nuclear
foci on sites of DNA double strand breaks (Rogakou et
al., 1999). Similar to 
 
g
 
-H2AX (Rogakou et al., 1999), the
number of 53BP1 foci showed a linear relationship with
the severity of DNA damage (Fig. 1 and data not
shown). As shown in Fig. 2 A, damage-induced 53BP1
foci colocalized with 
 
g
 
-H2AX at the various time points
analyzed. The number of 53BP1 foci was identical to
that of 
 
g
 
-H2AX throughout the course of the experi-
ment. In addition, coimmunoprecipitation analysis re-
vealed that 53BP1 and 
 
g
 
-H2AX biochemically interact
after 
 
g
 
-radiation (Fig. 2 B). Small amounts of 53BP1
were detected in 
 
g
 
-H2AX immunoprecipitates prepared
from irradiated HBL100 cells. In unirradiated cells,
H2AX was not phosphorylated and anti–
 
g
 
-H2AX anti-
bodies did not immunoprecipitate any phosphorylated
H2AX. Similarly, 53BP1 was also not present in anti–
 
g
 
-H2AX immunoprecipitates prepared from unirradi-
ated cells. These results demonstrate that 53BP1 colocal-
izes and interacts with 
 
g
 
-H2AX at the sites of DNA
strand breaks after 
 
g
 
-radiation. 
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ATM Is Involved in 53BP1 Foci Formation
 
Several phosphatidylinositol 3–kinase (PI3K)-related ki-
nases, including DNA-dependent protein kinase (DNA-
PK), ATM, and ATM-related kinase (ATR), participate
in DNA damage–responsive pathways (Smith and Jack-
son, 1999; Khanna, 2000). It is possible that DNA dam-
age–induced 53BP1 foci formation may depend on one or
more of these PI3K-like kinase family members.
We first examined 53BP1 foci formation in the pres-
ence or absence of DNA-PK using two derivatives of
the human glioma cell line MO59 (Lees-Miller et al.,
1995). No difference in the time course of 53BP1 foci
appearance and disappearance was observed in these
two cell lines after exposure to 1 Gy of 
 
g
 
-radiation (data
not shown). However, comparison was hampered by the
high number of 53BP1 foci in unirradiated MO59K and
MO59J cells and subtle differences might be over-
looked.
We then examined whether the 53BP1 response to ion-
izing radiation is affected in cells lacking ATM. Immortal-
ized ATM-deficient fibroblasts (FT169A) were compared
with their isogenic derivative cells, YZ5, that have been
reconstituted with wild-type ATM cDNA (Ziv et al.,
1997). As shown in Fig. 3 A, although irradiation with
1 Gy resulted in a rapid formation of 53BP1 foci in
the ATM-reconstituted cells (ATM
 
1
 
), a reduced re-
sponse was observed in the cells lacking wild-type ATM
(ATM
 
2
 
). Similar results were obtained when we com-
pared other ATM-deficient fibroblast lines (GM03189D
and GM05849C) with wild-type ATM cell lines
(GM02184D and GM00637H) (Fig. 3 A). The time course
of the number of 53BP1 foci per cell, as calculated from
three independent experiments using YZ5 versus parental
FT169A cells, is illustrated in Fig. 3 B.
To further corroborate the role of ATM in 53BP1 foci
formation, we pretreated HeLa cells for 30 min with wort-
mannin before exposure to 1 Gy of irradiation. Wortman-
nin is a potent inhibitor of the PI3K-related kinases, in-
cluding ATM and DNA-PK (Sarkaria et al., 1998). As
shown in Fig. 3 C, pretreatment with 50 
 
m
 
M wortmannin
greatly reduced the number of 53BP1 foci evident 1 h after
 
g
 
-radiation. At an even higher dose (200 
 
m
 
M), wortman-
nin completely blocked 53BP1 foci formation. These re-
sults suggest that the kinase activities of ATM or other
PI3K-related kinases are required for 53BP1 foci forma-
tion.
Figure 1. 53BP1 forms nuclear foci in response to
DNA damage. HeLa cells were exposed to g-irradi-
ation (1 and 10 Gy) or a 50 J/m2 UV pulse 1 h be-
fore immunostaining with anti-53BP1 mAb
BP13. Alternatively, cells were treated for 1 h
with the following drugs: 2 mg/ml 4-nitroquino-
line 1-oxide (4NQO), 1 mM hydroxyurea (HU),
1 mM camptothecin (CPT), 40 mg/ml etoposide
(VP16), 0.01% methylmethanesulfonate (MMS),
40 mM cisplatin (CDDP), 1 mM 7-hydroxystauro-
sporine (UCN-01), and 1 mM paclitaxel (Taxol). 
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ATM Is Required for DNA Damage-induced 
Hyperphosphorylation of 53BP1
 
Many proteins involved in DNA damage–response and/or
DNA repair are phosphorylated upon DNA damage. To
examine whether 53BP1 becomes phosphorylated in re-
sponse to 
 
g
 
-radiation, K562 cells were irradiated (20 Gy)
and harvested 1 h later. After immunoprecipitation using
anti-53BP1 antisera, the samples were incubated for 1 h at
30
 
8
 
C in the presence or absence of 
 
l
 
 protein phosphatase
and separated on a 3–8% gradient SDS gel. Phosphatase
treatment of unirradiated K562 cells revealed a faster mi-
grating form of 53BP1 (Fig. 4 A). This indicates that
53BP1 is modified by phosphorylation in normal undam-
aged cells. Upon 
 
g
 
-radiation, 53BP1 showed an even
slower mobility that was reversed by phosphatase treat-
ment (Fig. 4 A). These results suggest that 53BP1 is phos-
phorylated in undamaged cells and becomes hyperphos-
phorylated after 
 
g
 
-radiation.
Since 53BP1 is hyperphosphorylated after 
 
g
 
-radiation,
we then examined whether wortmannin would affect radi-
ation-induced 53BP1 phosphorylation. As illustrated in
Fig. 4 B, there was no detectable radiation-induced 53BP1
mobility shift in wortmannin (50 
 
m
 
M)-pretreated cells. In
contrast, the radiation-induced 53BP1 mobility shift was
Figure 2. (A) 53BP1 colocal-
izes with g-H2AX in response
to  g-radiation. WI38 cells
were coimmunostained with
anti-53BP1 antibody BP13
and affinity-purified anti–
g-H2AX serum before (0
min) and at the indicated time
points after exposure to 1 Gy
(10–160 min). (B) Coimmuno-
precipitation of 53BP1 and
g-H2AX after DNA dam-
age. HBL100 cells were ex-
posed to 0 or 20 of Gy g-radi-
ation 1 h before lysis in
NETN buffer (150 mM NaCl,
1 mM EDTA, 20 mM Tris,
pH 8, 0.5% NP-40) including
0.3 M NaCl. Immunoprecipi-
tation experiments were per-
formed using anti-gH2AX or
anti-53BP1 antibodies. A five-
fold higher amount of cell
lysate was used for anti–
g-H2AX immunoprecipita-
tion than that used for anti-
53BP1 immunoprecipitation.
The samples were separated
on 4–15% SDS-PAGE and
Western blotting was per-
formed using either anti–
g-H2AX or anti-53BP1 anti-
bodies as indicated. 
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readily detected in cells that had received no drug treat-
ment before radiation. We next repeated the experiment
using the ATM-deficient GM03189D and GM02184D
cells expressing wild-type ATM. Again, in ATM wild-type
cells, 
 
g
 
-radiation induced a 53BP1 mobility shift in control,
but not in wortmannin-pretreated samples (Fig. 4 C).
However, no radiation-induced 53BP1 mobility shift was
observed in ATM-deficient cells, with or without wort-
mannin treatment (Fig. 4, C and D). Taken together, these
results strongly suggest that ATM is required for 53BP1
hyperphosphorylation after 
 
g
 
-radiation.
 
53BP1 Is a Substrate of ATM In Vitro
 
S/TQ sites have been described to be the minimal essential
recognition sites for ATM (Kim et al., 1999). 53BP1 con-
tains a total of 30 S/TQ sites, many of them clustered in the
Figure 3. 53BP1 foci formation is reduced in cells lacking ATM.
(A) ATM-deficient cell lines (FT169A, GM03189D, and
GM05849C) and wild-type ATM cell lines (YZ5, GM02184D,
and GM00637H) were irradiated with 1 Gy and immunostained
with anti-53BP1 mAb BP13 at different time points before and
after irradiation as indicated. FT169A cells and YZ5 cells are isogenic, whereas the other lines are unrelated. (B) The numbers of 53BP1
foci in at least 75 FT169A (ATM2) and YZ5 (ATM1) cells were counted for each time point. Data represent mean 6 SD of three in-
dependent experiments. The difference in foci number between ATM1 and ATM2 cells 10 or 20 min after irradiation was significant
at P , 0.001 using a Student’s t test. (C) Wortmannin inhibits g-radiation–induced 53BP1 foci formation. HeLa cells were pretreated for
30 min with 0, 50, or 200 mM wortmannin before exposure to 1 Gy of g-radiation. After recovery for 1 h, the control or irradiated cells
were immunostained with anti-53BP1 antibodies. 
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NH
 
2
 
-terminal region. To examine whether 53BP1 is a sub-
strate for ATM, and to define regions that can be phos-
phorylated by ATM in vitro, we designed six overlapping
53BP1 GST fragments that span the entire ORF of 53BP1
and performed a standard ATM kinase assay. As shown in
Fig. 4 E, the first three NH
 
2
 
-terminal 53BP1 fragments
were phosphorylated by ATM in vitro, whereas no phos-
phorylation was observed in the last three COOH-termi-
nal fragments, despite the fact that there are a total of 10
S/TQ sites within these 53BP1 fragments. These data sug-
gest that 53BP1 is a substrate of ATM kinase.
 
Discussion
 
Here we report that 53BP1 participates in the early DNA
damage–response. Using several antibodies specifically
recognizing 53BP1, we show that 53BP1 becomes hyper-
phosphorylated and forms nuclear foci after exposure to
ionizing radiation. 
 
g
 
-Radiation–induced 53BP1 hyper-
phosphorylation and foci formation are reduced in ATM-
deficient cells. Moreover, 53BP1 hyperphosphorylation, as
well as foci formation, is inhibited by wortmannin, an in-
hibitor of the PI3K-related kinases including ATM, DNA-
PK, and, to a lesser extent, ATR (Sarkaria et al., 1998).
Taken together, these data suggest that ATM and other
PI3K-related kinases directly phosphorylate 53BP1 and
regulate its localization to the sites of DNA strand breaks.
In favor of a functional link between ATM and 53BP1,
we also demonstrate that NH
 
2
 
-terminal fragments of
53BP1 are effectively phosphorylated by ATM in vitro.
Similarly, Xia and colleagues have recently shown that 
 
Xe-
nopus
 
 53BP1 and a NH
 
2
 
-terminal fragment of human
53BP1 can be phosphorylated by ATM in vitro and in vivo
(Xia et al., 2000), supporting our hypothesis that 53BP1 is
a direct substrate of ATM. In contrast to our findings,
Schultz et al. (2000) observed no difference in 53BP1 foci
formation in ATM-deficient cells when compared with
that in normal ATM wild-type cells (Schultz et al., 2000).
We also observed that 53BP1 foci still formed, albeit with
slower kinetics, in cells lacking ATM, suggesting the exist-
Figure 4. g-Radiation–induced hyperphosphor-
ylation of 53BP1 requires ATM. (A) g-Radia-
tion induces hyperphosphorylation of 53BP1.
K562 cells were exposed to 0 or 20 Gy of g-radi-
ation and immunoprecipitated using polyclonal
anti-53BP1 antibody. Immunoprecipitates were
incubated for 1 h at 308C with 800U l-phos-
phatase (lPPase) in 100 ml incubation buffer or
only incubation buffer. The samples were sepa-
rated on a 3–8% gel and immunoblotted with
anti-53BP1. (B) Wortmannin inhibits 53BP1 hy-
perphosphorylation. K562 cells were pretreated
with 50 mM wortmannin for 30 min before expo-
sure to 1 Gy of radiation. Whole cell lysates pre-
pared from treated and control samples were
separated on a 3–8% gradient gel (30 mg protein
per lane) and immunoblotted with anti-53BP1
antibodies. (C) ATM is required for the g-radia-
tion–induced hyperphosphorylation of 53BP1.
ATM-deficient GM03189D cells or ATM wild-
type GM02184D cells were treated as described
in the legend to B, and 30 mg lysates were sepa-
rated on a 3–8% gel before immunoblotting with
anti-53BP1 antibodies. (D) All three ATM-defi-
cient cell lines tested (FT169A, GM03189D, and
GM05849C) show no hyperphosphorylation 1 h
after 20 Gy. (E) 53BP1 is a substrate of ATM in
vitro. Six GST fusion proteins containing over-
lapping 53BP1 fragments were used as substrates
in an ATM in vitro kinase assay. GST protein
alone and GST fusion protein containing 13 resi-
dues surrounding the serine-15 of the p53 coding
sequence were used, respectively, as negative
and positive controls. 
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ence of an alternative, ATM-independent pathway for the
regulation of 53BP1. However, our data presented here
clearly demonstrate that ATM plays a critical role in the
regulation of 53BP1 hyperphosphorylation and foci for-
mation after 
 
g
 
-radiation.
53BP1 rapidly colocalizes with 
 
g
 
-H2AX in response to
ionizing radiation. H2AX is a histone H2A variant that be-
comes phosphorylated and forms foci at sites of DNA
strand breaks after DNA damage (Rogakou et al., 1999;
Paull et al., 2000). The number, as well as appearance and
disappearance of 53BP1 foci, matched almost completely
with that of 
 
g
 
-H2AX. Moreover, 53BP1 and 
 
g
 
-H2AX
physically interact after ionizing radiation, suggesting that
53BP1 relocates to the sites of DNA double strand breaks
in response to 
 
g
 
-radiation. Similar to 53BP1, 
 
g-H2AX foci
formation is inhibited by wortmannin treatment (Rogakou
et al., 1999; Paull et al., 2000) and is reduced in ATM-defi-
cient cells (Rappold, I., and J. Chen, unpublished observa-
tion). It is possible that phosphorylation of H2AX may
mediate the relocalization of 53BP1 to DNA strand
breaks. If this is the case, ATM-dependent hyperphos-
phorylation of 53BP1 may be a secondary event that is not
required for 53BP1 foci formation. This possibility will be
examined in future studies using phosphorylation-defi-
cient mutants of 53BP1.
Upon relocalizing to the sites of DNA damage, 53BP1
could participate in chromosome remodeling that makes
DNA lesions accessible to DNA repair proteins. Alterna-
tively, 53BP1 could be involved in the recruitment of re-
pair proteins like BRCA1 and Rad51 to these DNA le-
sions. Both of these proteins colocalize with 53BP1
several hours after exposure to ionizing radiation (Rap-
pold, I., and J. Chen, unpublished observations). In ad-
dition, BRCA1 biochemically interacts with 53BP1 after
g-radiation (Rappold, I., and J. Chen, unpublished obser-
vations).
53BP1 contains two BRCT motifs at its COOH termi-
nus. 53BP1 BRCT motifs are closely related with those of
BRCA1 and Saccharomyces cerevisiae Rad9 (scRad9)
protein. Insight into the potential role of scRad9 comes
from studies of its association with scRad53. ScRad53 is
the homologue of mammalian Chk2 or Schizosaccharomy-
ces pombe Cds1. After DNA damage, scRad9 is phosphor-
ylated and this phosphorylated scRad9 associates with the
forkhead homology–associated (FHA) domain of scRad53
(Sun et al., 1998; Vialard et al., 1998). Mutations in ei-
ther  the scRad53 FHA domain (Sun et al., 1998) or
scRad9 BRCT motifs (Soulier and Lowndes, 1999) pre-
vent scRad53 activation after DNA damage. Although the
mammalian homologue of scRad9 has not been identified,
a scRad9 homologue likely exists in mammals. Because of
the close homology of their BRCT motifs, two candidate
scRad9 homologues are BRCA1 and 53BP1. Based on
yeast studies, one would predict that the activation of
Chk2, the homologue of scRad53, should depend on this
scRad9 homologue in mammalian cells. However, DNA
damage–induced phosphorylation of Chk2 was observed
in BRCA1-deficient cells (Matsuoka et al., 1998), suggest-
ing that BRCA1 may not be the mammalian homologue of
scRad9. Experiments using 53BP1-deficient cells will be
performed to examine whether 53BP1 is the scRad9 ho-
mologue in mammals.
In conclusion, our data demonstrate that 53BP1 partici-
pates early in DNA damage–signaling pathways and is
regulated by ATM after g-radiation. The exact role of
53BP1 in these pathways remains to be resolved. Given
the importance of these DNA damage–signaling pathways
in cancer prevention, it will be interesting to examine
whether 53BP1 is mutated in tumors.
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